Replies to post #26 on 89bio Inc (ETNB)

[subslover]

What a HUGE call. Many congrats to you!
89bio shares are trading higher after the company's Phase 2b ENLIVEN trial of pegozafermin in NASH achieved statistical significance on both primary histology endpoints.
by
Bill Haddad, Benzinga Editor
March 22, 2023 7:49 AM | 18 seconds read